Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venetoclax + R-ICE in R/R DLBCL
NCT03064867Phase 2Active, not recruiting
- Start
- Jun 2017
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in diffuse large B-cell lymphoma (DLBCL). Started Jun 2017; status: active, not recruiting.
02
Drugs
venetoclax
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT03064867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03064867.